XORTX Therapeutics 대차 대조표 상태
재무 상태 기준 확인 6/6
XORTX Therapeutics has a total shareholder equity of $2.7M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $4.8M and $2.1M respectively.
주요 정보
0%
부채 비율
US$0
부채
| 이자 보상 비율 | n/a |
| 현금 | US$3.08m |
| 주식 | US$2.70m |
| 총 부채 | US$2.09m |
| 총 자산 | US$4.80m |
최근 재무 상태 업데이트
Recent updates
Here's Why We're Watching XORTX Therapeutics' (CVE:XRTX) Cash Burn Situation
Aug 23
XORTX Therapeutics (CVE:XRTX) Is In A Strong Position To Grow Its Business
Apr 01We're Interested To See How XORTX Therapeutics (CVE:XRTX) Uses Its Cash Hoard To Grow
Dec 16Companies Like XORTX Therapeutics (CSE:XRX) Can Afford To Invest In Growth
Sep 01재무 상태 분석
단기부채: XRTX's short term assets ($3.4M) exceed its short term liabilities ($437.9K).
장기 부채: XRTX's short term assets ($3.4M) exceed its long term liabilities ($1.7M).
부채 대 자본 내역 및 분석
부채 수준: XRTX is debt free.
부채 감소: XRTX has no debt compared to 5 years ago when its debt to equity ratio was 227.9%.
대차 대조표
현금 런웨이 분석
과거에 평균적으로 적자를 기록했던 기업의 경우, 최소 1년 이상의 현금 유동성을 보유하고 있는지 평가합니다.
안정적인 현금 활주로: XRTX has sufficient cash runway for 8 months based on last reported free cash flow, but has since raised additional capital.
예측 현금 활주로: XRTX is forecast to have sufficient cash runway for 7 months based on free cash flow estimates, but has since raised additional capital.